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The cyc1-512 mutation in Saccharomyces cerevisiae causes a 90% reduction in the level of iso-1-cytochrome c
because of the lack of a proper 3*-end-forming signal, resulting in low levels of eight aberrantly long cyc1-512
mRNAs which differ in length at their 3* termini. cyc1-512 can be suppressed by deletion of either of the
nonessential genes CBC1 and CBC2, which encode the CBP80 and CBP20 subunits of the nuclear cap binding
complex, respectively, or by deletion of the nonessential gene UPF1, which encodes a major component of the
mRNA surveillance complex. The upf1-D deletion suppressed the cyc1-512 defect by diminishing degradation
of the longer subset of cyc1-512 mRNAs, suggesting that downstream elements or structures occurred in the
extended 3* region, similar to the downstream elements exposed by transcripts bearing premature nonsense
mutations. On the other hand, suppression of cyc1-512 defects by cbc1-D occurred by two different mechanisms.
The levels of the shorter cyc1-512 transcripts were enhanced in the cbc1-D mutants by promoting 3*-end
formation at otherwise-weak sites, whereas the levels of the longer cyc1-512 transcripts, as well as of all
mRNAs, were slightly enhanced by diminishing degradation. Furthermore, cbc1-D greatly suppressed the
degradation of mRNAs and other phenotypes of a rat7-1 strain which is defective in mRNA export. We suggest
that Cbc1p defines a novel degradation pathway that acts on mRNAs partially retained in nuclei.
The lack of normal transcription termination or 39-end pro-
cessing of mRNAs can lead to drastic reductions in gene ex-
pression, as exemplified by the cyc1-512 mutation of the CYC1
gene, which encodes iso-1-cytochrome c in Saccharomyces cer-
evisiae. The cyc1-512 mutation, consisting of a 38-bp deletion,
8 nucleotides (nt) upstream from the normal poly(A) site, was
found to cause an approximately 90% diminution in the CYC1
mRNA and in the corresponding iso-1-cytochrome c protein
(88). The cyc1-512 mRNAs were aberrantly long, with many
discrete 39 termini ranging from the wild-type poly(A) site to
endpoints greater than 2,000 nucleotide (nt) downstream. Ap-
parently, the lack of the normal 39-end-forming signals resulted
in partial termination or processing at various sites beyond the
normal poly(A) site. The abnormally long mRNAs were sug-
gested to be rapidly degraded (88).
Genetic analysis revealed the following three types of cyc1-
512 revertants that were isolated on lactate medium, a medium
that requires increased levels of iso-1-cytochrome c for growth:
(i) single- or multiple-base pair changes, resulting in intragenic
revertants that contained new 39-end-forming signals at various
sites in the 39 untranslated region of CYC1; (ii) gross chromo-
somal aberrations that resulted in the formation of abnormal
39 regions; and (iii) extragenic suppressors that enhanced the
levels of the cyc1-512 mRNA and of iso-1-cytochrome c by up
to approximately fourfold (39, 89). The cyc1-512 suppressors
constituted recessive mutations that could be assigned to at
least two loci, which were designated SUT1 and SUT2 (39, 89).
As shown in this study, complementation of the suppressors
sut1-2 (now designated cbc1-2) and sut2-2 (now designated
upf1-102) and DNA sequencing of the appropriate cloned frag-
ments revealed that SUT1 and SUT2 correspond to the previ-
ously identified genes CBC1 and UPF1, respectively. CBC1
encodes a protein corresponding to the orthologous nuclear
cap binding protein, CBP80, in animal cells (16, 28, 29), where-
as UPF1 encodes one of the major components of the non-
sense-mediated mRNA decay (NMD) pathway (9, 12, 32, 41,
62, 84). Furthermore, the examination of the abundance and
half-lives of cyc1-512 mRNAs and other normal mRNAs in
cbc1-D and upf1-D strains revealed that Cbc1p may be a com-
ponent of a novel nuclear mRNA decay pathway and that
mRNAs with extended 39 ends can be degraded by the NMD
pathway. Also, studies with cbc1-D strains demonstrated that
Cbc1p apparently is required to prevent promiscuous 39-end
formation.
MATERIALS AND METHODS
Genetic nomenclature. The wild-type allele encoding iso-1-cytochrome c is
designated CYC1 or CYC11. Mutant alleles that produce either normal or
decreased levels of iso-1-cytochrome c are designated cyc1 followed by the allele
number, e.g., cyc1-512. CBC1 (or CBC11), for example, denote the wild-type
alleles. The cbc1-2, sut2-2, etc., gene symbols designate recessive mutant alleles,
whereas cbc1-D or cbc1::URA3, for example, denotes a disruptant of CBC1.
CBC1 was previously designated SUT1 (39, 89), GCR3 (77, 78), and STO1
(11), whereas CBC2 has also been designated MUD13 (11). UPF1 was previously
designated SUT2 (39, 89) before its identification. As mentioned above, the
suppressors sut1-1 and sut1-2, etc., are now designated cbc1-1 and cbc1-2, etc.,
whereas the suppressors sut2-1 and sut2-2, etc., are now designated upf1-101 and
upf1-102, etc.
Strains, media, and yeast genetics. The strains of S. cerevisiae used in this study
are listed in Table 1. lDE3 lysogens of Escherichia coli strain BL21 (F2 ompT
rB2 mB2) (76) was used for the expression of a portion of Cbc1p. Standard YPD,
YPG, SC-Ura (uracil omission), SC-Leu (leucine omission), and other omission
media were used for yeast propagation and testing (70); chlorolactate medium
was used for the cloning of CBC1 and UPF1 genes (71). Yeast genetic analysis
was carried out by standard procedures described by Sherman (70).
Determination of cytochrome c content. Total amounts of cytochrome c were
determined by spectroscopic examination of intact cells at 2196°C (71) and by
comparing the intensities of the c Ca bands at 547 nm to strains having known
amounts of cytochrome c. More accurate determinations of cytochrome c con-
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tent in intact cells were made by low-temperature (2196°C)-spectrum recordings
using a modified Cary 14 spectrophotometer (25).
Oligonucleotides. Oligonucleotides used for oligonucleotide-directed mu-
tagenesis, sequencing, primer extension, and PCR were synthesized on an Ap-
plied Biosystems 380A DNA synthesizer.
Plasmid construction. Plasmids designated pAB1158, pAB1159, pAB1160,
pAB1733, and pAB1734 were independently isolated from an S. cerevisiae
genomic library constructed in plasmid YCp50 (59) using the complementation
strategy outlined below. pAB1101 was derived from pAB1160 by deleting a 6-kb
SalI fragment and was used to sequence the CBC1 gene. A 4.2-kb ClaI fragment
from pAB1101, containing the CBC1 coding region and flanking sequences, was
inserted into pAB625, resulting in the plasmid pAB1137. The pAB1137 plasmid
was used to make mutations in the CBC1 gene by site-directed mutagenesis.
pAB1135 was constructed by ligating a 4.5-kb SalI-HindIII fragment from
pAB1101 into YEp51. The plasmid used for disrupting the CBC1 gene,
pAB1100, was constructed by inserting a 2.1-kb SalI-BamHI fragment, which
contained the CBC1 gene, from pAB1101 into the Bluescript SK vector (Strat-
agene) and subsequently inserting a 1.1-kb HindIII fragment, which contained
the URA31 gene from pYc5, into the HindIII site within the CBC1 gene. pAB81
was derived by inserting a 2.5-kb EcoRI fragment, containing the cyc1-512 allele,
into pBR322. pAA1735 corresponds to the plasmid YCpPL63 described by
Leeds et al. (42).
The blaster pAB2207 plasmid, used to disrupt CBC11, was constructed in
three steps. Initially, a 4.5-kb SalI-HindIII fragment containing the CBC11
coding region and the flanking sequence from pAB1101 was inserted into a
pUC19 vector. In the next step, a 1.25-kb BamHI-BglII fragment was deleted
from the CBC11 coding region and subsequently replaced by 3.8-kb BamHI-
BglII blaster fragment containing a functional yeast URA31 gene flanked by
1.1-kb direct repeats of Salmonella enterica serovar Typhimurium hisG DNA
from pNKY51 (1).
Transformation, nucleic acid isolation, and manipulation. S. cerevisiae cul-
tures were transformed with plasmid DNA for complementation analysis and
with linear DNA for gene disruption (60) by using the lithium acetate method
(27) followed by selection on SC-Ura (uracil omission) or SC-Leu (leucine
omission) medium. Plasmid DNA was isolated from transformed S. cerevisiae
strains as described previously (72). The yeast chromosomal gene CBC1 was
disrupted by transforming the appropriate yeast strains with DNA fragments that
were prepared either by digesting the plasmid pAB1100 with SalI and BamHI or
by digesting the blaster plasmid pAB2207 with PvuII and XbaI. Similarly, the
UPF1 gene on the chromosome was disrupted by transforming the suitable yeast
strains with DNA fragments that were prepared by digesting the plasmid
YCpPL51 (42), with BamHI and EcoRI. The Escherichia coli strains HB101 and
XL1-Blue were transformed by the protocol of Hanahan (22). Standard tech-
niques of DNA manipulation, such as cloning, subcloning, and sequencing, used
in this study are described by Sambrook et al. (67). Nucleic acid and protein
sequences were analyzed by using the computer programs FASTA, TFASTA,
BESTFIT, and BLAST from the University of Wisconsin Genetics Computer
Group software version 7.0.
Cloning the CBC11 and UPF11 genes. The cbc1-2 mutation was originally
isolated as a suppressor of cyc1-512 (39, 89). The wild-type CBC11 gene was
cloned by complementing the cbc1-2 suppressor in strain B-9036 (Table 1) with
a YCp50-based yeast genomic library. Briefly, approximately 105 Ura1 transfor-
mants were collected and plated on chlorolactate medium. Generally, strains
with diminished levels of iso-1-cytochrome c form larger colonies on chlorolac-
tate medium because of decreased utilization of chlorolactate, which is toxic (71).
Approximately 50 large chlorolactate colonies were tested for levels of iso-1-
cytochrome c by low-temperature (2196°C) spectroscopic examination of intact
cells. Those strains having diminished levels of iso-1-cytochrome c were further
tested for the levels after loss of the plasmid by isolating Ura2 strains on
5-fluoroorotic acid medium. This screen resulted in the identification of three
strains with lower levels of iso-1-cytochrome c in a plasmid-dependent manner.
Plasmid DNA was extracted from these three yeast strains, amplified in E. coli,
and shown by restriction endonuclease analysis to encompass a common region.
Furthermore, Northern blot analysis showed that yeast strains harboring any one
of these three plasmids contained the expected 10% of the CYC1 mRNA, similar
to cyc1-512 strains (data not presented).
DNA sequencing and subsequent computer analysis of the relevant segment of
the complementing plasmid revealed a 2,574-bp open reading frame (ORF) and
the TACTAAC motif upstream of the ORF, which is indicative of an intron (data
not shown). In addition, the putative 59 and 39 splicing sites could be theoretically
assigned by considering the conserved sequences (86), and these assignments
were confirmed by sequencing the appropriate region of the CBC1 cDNA. The
presence of a 322-nt-long intron near the 59 end was also confirmed by others
(73, 78).
The 59 ends of the CBC1 transcripts were mapped by primer extension to a
60-bp region from 236 to 296 nt. The major transcription initiation site was
located at position 273, flanked by several minor sites (data not presented).
Interestingly, all the 59 ends aligned at purine residues, and usually at A residues;
only the 236 position was at a G residue. The predicted translation product for
CBC1 is 861 amino acids long, a size that would correspond to a protein of
100,017 Da. Comparison of Cbc1p protein with database sequences by using the
BLAST method revealed that CBC1 is identical to GCR3, a gene involved in
expression of the glycolytic genes of yeast (77). However, the initial published
amino acid sequence of GCR3 is not identical to that of our deduced amino-
terminal region because the intron of GCR3 was not considered by the authors
and was included as part of the ORF.
TABLE 1. Yeast strains
Strain Genotypea
D311-3A ..............................MATa CYC11 his1-1 lys2-1 trp2-1
B-4060..................................MATa cyc1-512 his1-1 lys2-1 trp2-1
B-5419..................................MATa cyc1-512 his1-1 lys2-1 cbc1-2 (sut1-2) trp2-1
B-9037..................................MATa cyc1-512 trp2-1 ura3-52
B-9038..................................MATa cyc1-512 trp2-1 ura3-52 cbc1::URA3
B-9848..................................MATa cyc1-512 trp2-1 ura3-52 upf1::URA3
B-11559................................MATa cyc1-512 trp2-1 ura3-52 cbc1::hisG upf1::URA3
B-12463................................MATa cyc1-512 trp2-1 ura3-52 cbc2::URA3
B-9036..................................MATa cyc1-512 cbc1-2 ura3-52
B-9045..................................MATa cyc1-512 cbc1-2::URA3 ura3-52
B-9849..................................MATa cyc1-512 cbc1-2 upf1::URA3 ura3-52
B-9962..................................MATa cyc1-512 upf1-102 (sut2-2) ura3-52
B-6304..................................MATa cyc1-512 leu2-1
B-9042..................................MATa cyc1-512 leu2-1 pAB1135
B-7999..................................MATa cyc1-947 cyc7-67 leu2-3 leu2-112 ura3-52 cyhR2
B-9039..................................MATa cyc1-947 cyc7-67 leu2-1 leu2-112 cbc1::URA3 ura3-52 cyhR2
B-6978..................................MATa CYC11 cyc7-67 can1-100 ilv3 leu2-3 leu2-112 ura3-52
B-9040..................................MATa CYC11 cyc7-67 can1-100 ilv3 leu2-3 leu2-112 cbc1::URA3 ura3-52
B-11623................................MATa cyc1-72 aro7-1 his4-166 leu2-1 lys2-187 met8-1 ura3-52
B-9198..................................MATa cyc1-72 aro7-1 his4-166 leu2-1 lys2-187 met8-1 ura3-52 cbc1::URA3
B-9199..................................MATa cyc1-72 aro7-1 his4-166 leu2-1 lys2-187 met8-1 ura3-52 upf1::URA3
B-10603................................MATa his3-D200 ura3-52 leu2-D1
B-10099................................MATa his3-D200 ura3-52 leu2-D1 cbc1::URA3
B-10095................................MATa his3-D200 ura3-52 leu2-D1 rat7-1
B-10096................................MATa his3-D200 ura3-52 leu2-D1 rat7-1 cbc1::URA3
B-10097................................MATa his3-D200 ura3-52 leu2-D1 rat7-1 upf1::URA3
D-890 ...................................MATa/MATa cyc1-1/cyc1-1 CYC7-H2/CYC7-H2 ARO7/aro7-1 HIS1/his1 LEU1/leu1-12 LYS2/lys2 TRP2/trp2 ura3/ura3
a Gene symbols in parentheses designate earlier synonyms (see Materials and Methods).
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UPF1 was cloned similarly by the method used to clone CBC1, except that
strain B-9962 (cyc1-512 upf1-102 [sut2-2] ura3-52) (Table 1) was transformed
with the yeast genomic library. Approximately 5 3 105 Ura1 transformants were
transferred to chlorolactate plates, and the 87 largest colonies were chosen for
spectral examination. Four of them were found to have diminished levels of
cytochrome c compared to the parental strain. Plasmids from these four trans-
formants were isolated and used to transform the strain B-9962. Two of these
four transformants again contained reduced levels of cytochrome c. Restriction
mapping demonstrated that these two plasmids contained the same insert, which
was approximately 10 kb in size. Approximately 200-nt sequences at both ends of
one insert were determined and compared to the GenBank database. The results
revealed that the insert corresponded to a segment in chromosome XIII extend-
ing from nt 4354 to 13464 of cosmid 9582, accession number Z492559. This
region of chromosome XIII contains the following genes: CHL12 (4522 to 6747),
SEC14 (7008 to 8078), UPF1 (8731 to 11646), and MBR3 (12098 to 13114).
Because UPF1 is required for the rapid degradation of certain abnormal mRNAs
(see below), strain B-9962 was transformed with plasmid pAA1735 (YCpPL63)
(42), which contains the UPF1 gene. Since the level of iso-1-cytochrome c
diminished from 30 to 10% in the sut2-2 transformants bearing the wild-type
UPF11 gene in plasmid pAA1735, sut2-2 was considered to be complemented by
UPF11, and consequently, SUT2 is considered to correspond to UPF1. In addi-
tion, as described below, disruption of UPF1 leads to suppression of cyc1-512.
Analysis of mRNA steady-state levels and stability. The stabilities of the
various mRNAs and the pre-mRNA were determined by the inhibition of tran-
scription with 4 mg of thiolutin/ml at 30°C, as described by Herrick et al. (24).
Total RNA was isolated as described by Russo et al. (65) from approximately 108
cells, and enriched poly(A) RNA was isolated from a total of 1 mg of total RNA
with the Oligotex mRNA kit (Qiagen Inc., Valentia, Calif.) as recommended by
the vendor. Northern blot analyses of different mRNAs were conducted as
outlined by Russo et al. (65). Messenger RNA levels were quantified by storage
PhosphorImager analysis (model 425E; Molecular Dynamics) and normalized
against the 18S rRNA signals when total RNA was used. Signals were normalized
against ACT1 mRNA when poly(A) mRNA was used.
The decay rates and half-lives were estimated with the SigmaPlot (version 4.0)
regression analysis program, using either a single-exponential decay formula, y 5
100 e2bx, or a four-parameter double-exponential decay formula, y 5 ae2bx 1
ce2dx (a 1 c 5 100). The variance was estimated by a nonlinear least-squares
regression analysis using the S-Plus software package, version 3.4 (Mathsoft Inc.,
Cambridge, Mass.).
Antibody production. An XhoI restriction site was created 19 bp upstream
from the CBC1 39 splicing site in pAB1137 by site-directed mutagenesis (40). The
resulting XhoI-BamHI fragment, containing 175 codons of exon 2 of CBC1, was
inserted in frame into the expression vector pET15b (Novagene), resulting in the
plasmid pAB1133. The E. coli expression host BL21 (DE3) was transformed with
pAB1133, and the expression of the target protein was induced by adding IPTG
(isopropyl-b-D-thiogalactopyranoside) to the medium (76). The 25-kDa Cbc1p
fragment, constituting approximately 90% of the inclusion body proteins, was
washed twice with washing buffer (2% Triton X-100, 50 mM Tris-HCl, and 2 mM
EDTA, pH 7.5) and used by Pocono Rabbit Farm (Canadensis, Pa.) to generate
rabbit polyclonal antibodies.
Indirect immunofluorescence and Western blot analysis. Cells grown in SC-
Leu medium were fixed with 4% formaldehyde at room temperature for 2 h.
Spheroplasts were prepared with zymolase 100T (ICN Immunobiologicals) and
immobilized on polylysine-coated slides (79). Primary-antibody incubation was
performed at 4°C overnight with 10,000-fold-diluted anti-Cbc1p antiserum or
preimmune serum. The secondary antibody, Texas red-conjugated goat anti-
rabbit immunoglobulin G, was incubated for 30 min at room temperature at a
dilution of 1:100. Nuclei were stained with 1 mg of 49,6-diamidino-2-phenylindole
(DAPI)/ml.
Total yeast proteins (14) were separated by sodium dodecyl sulfate–10%
polyacrylamide gel electrophoresis and transferred electrophoretically to nitro-
cellulose filters. To detect Cbc1p, the blotted filters were first blocked with
phosphate-buffered saline (100 mM NaCl and 100 mM Na2HPO4, pH 7.5)
containing 5% nonfat dry milk. After incubation with the primary anti-Cbc1p
antiserum at a 1:5,000 dilution for 1 h at room temperature, the blots were
washed with a solution of phosphate-buffered saline and 0.1% Tween 20 and
incubated with the secondary antibody, horseradish peroxidase-linked donkey
anti-rabbit antibody (Amersham), at a dilution of 1:3,000. The Cbc1p band was
subsequently detected with an enhanced chemiluminescence kit (Amersham).
RESULTS
Suppression of cyc1-512 by cbc1-D, cbc2-D, and upf1-D. The
mechanism of suppression of the cyc1-512 mutation was inves-
tigated by identifying the genes corresponding to the sut1 and
sut2 suppressors. As described in Materials and Methods, clon-
ing of these two suppressors by complementation and subse-
quent sequencing revealed that these suppressors correspond-
ed to the previously known nonessential genes CBC1 and UPF1,
respectively.
CBC1 encodes the large subunit of the nuclear cap binding
complex (CBC), CBP80, which influences a number of impor-
tant functions in the maturation and export of capped RNAs
(16, 28, 29). CBC1 encodes an 861-amino-acid protein and
contains a 322-nt-long intron in the 59 end of the translated
region (data not shown). The yeast Cbc1p is 16.7% identical
and 33% similar to the mammalian CBP80. The other suppres-
sor, UPF1, plays a major role in the NMD decay pathway (9,
12, 32, 41, 61, 83).
It was originally suggested that the cbc1-2 suppressor coded
for a protein with an altered function which might enhance the
39-end formation of the aberrant cyc1-512 transcripts (89). This
hypothesis was tested by disrupting CBC1 in the haploid strains
B-9037 (cyc1-512 CBC11) and B-9036 (cyc1-512 cbc1-2) (Ta-
ble 2), which produced 10 and 45% of the normal level of
iso-1-cytochrome c, respectively. cbc1-2 appeared to be equiv-
alent to a null mutation, since the phenotypes of the cyc1-512
strains with a disruption of the CBC11 gene or with the cbc1-2
allele were identical, having the same amount of iso-1-cyto-
chrome c (Table 2). Furthermore, cbc1-D did not affect the
expression of CYC11, a finding which was consistent with the
observation that cbc1-2 did not cause an increase in the level of
iso-1-cytochrome c in a CYC11 background (89). In addition,
cbc1-D did not affect the expression of the cyc1-947 allele that
contained a normal 39 untranslated region but that was greatly
reduced in transcription due to the lack of TATA elements
(Table 2) (44), suggesting that neither cbc1-2 nor cbc1-D af-
fects the rate of transcription.
The finding that disruption of CBC11 had the same pheno-
type as cbc1-2, along with the previous observation that cbc1-2
caused an increase in the cyc1-512 mRNA level (89), raised the
possibility that cbc1-2 or cbc1-D could act by increasing the
stability of cyc1-512 mRNA. Therefore, we investigated the
stabilities and decay rates of a number of mRNAs in an iso-
genic series of strains to test this hypothesis (see below).
In order to examine whether mutation of either of the com-
ponents of CBC could suppress the cyc1-512, we also disrupted
the CBC21 gene (11) in the haploid strain B-9037 (cyc1-512
CBC21). Determination of the level of iso-1-cytochrome c in
the resulting B-12463 strain (cyc1-512 cbc2-D) showed that
disruption of CBC21 has the same phenotype as that obtained
with the disruption of the CBC11 gene (Table 2).
Examination of the levels of iso-1-cytochrome c in the iso-
genic series of strains listed in Tables 2 and 3 revealed that
upf1-D suppresses cyc1-512 to approximately the same extent
as cbc1-D and that the double mutant, cbc1-D upf1-D, was not
more effective than either of the single mutants (see Discus-
sion).
TABLE 2. Disruption of CBC1 in haploid strains
Strain Relevant genotype % Normal iso-1-cytochrome c
B-9037 cyc1-512 CBC11 10
B-9038 cyc1-512 cbc1::URA3 45
B-9848 cyc1-512 upf1::URA3 30
B-11559 cyc1-512 cbc1::hisG upf1::URA3 45
B-12463 cyc1-512 cbc2::URA3 45
B-9036 cyc1-512 cbc1-2 45
B-9045 cyc1-512 cbc1-2::URA3 45
B-7999 cyc1-947 CBC11 5
B-9039 cyc1-947 cbc1::URA3 5
B-6978 CYC11 CBC11 100
B-9040 CYC11 cbc1::URA3 100
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Disruption of CBC1 or CBC2 diminished cell growth on
glucose medium. To determine the phenotype of a null mutant
at the CBC1 locus, one copy of CBC1 in a diploid strain, D-890
(Table 1), was disrupted. Analysis of 11 complete tetrads from
a Ura1 transformant showed that all spores were viable and
that the Ura1 marker segregated 2:2. Disruption of CBC1 by
integration of the URA3 gene was confirmed by PCR amplifi-
cation of chromosomal DNA isolated from the Ura1 seg-
regants. Thus, CBC1 is not essential for cell viability.
Although it was not lethal, disruption of CBC1 or CBC2
greatly diminished cell growth on glucose medium (YPD),
indicating an important role for Cbc1p in normal cell growth.
In contrast, CBC11, cbc1-D, and cbc2-D strains grew nearly the
same on nonfermentable glycerol medium (YPG) and fer-
mentable raffinose medium (YPR) (Fig. 1), which extends the
early results of Uemura and Jigmi (77), who reported similar
findings with YPD and YPG.
Cbc1p is located in the nucleus. The amino-terminal region
of the deduced Cbc1 protein included two basic sequences,
NRKRR (residues 3 to 7) and RPRMPKRQR (residues 20 to
28), which could serve as nuclear localization signals. Although
the actual roles of the two basic regions have not been deter-
mined experimentally, their presence at the amino-terminal
region strongly suggests that Cbc1p is localized in the nucleus.
Because of its low abundance in normal cells, Cbc1p could not
easily be detected in strain B-6304 by either Western blot or
indirect immunofluorescence analysis. However, Cbc1p be-
came detectable by overexpression of CBC1 with a 2mm plas-
mid, pAB1135. Cbc1p, detected by Western blot analysis, was
approximately 100 kDa, agreeing with its predicted molecular
mass (data not shown). Furthermore, strain B-9042, containing
pAB1135, was prepared for immunofluorescence microscopic
analysis. Experiments with highly diluted anti-Cbc1p antisera
demonstrated that Cbc1p was located in the nuclei of the cells,
as was evident from the coincident Texas red and DAPI stains
(data not shown).
To rule out the possibility that Cbc1p could be mislocated to
the nucleus by overexpression, an extract prepared from the
normal strain B-6304 was fractionated into subcellular compo-
nents (69). The location of Cbc1p was monitored by protein
blot analysis of the proteins in subcellular fractions. Cbc1p
could be readily detected in the nuclear fraction of strain
B-6304 but not in the cytosol fraction or the total extract (data
not shown). Similarly, Go¨rlich et al. (16) used immunoelectron
microscopy to demonstrate that Cbc1p was located primarily in
the nucleus of yeast.
The cyc1-512 mRNAs. Northern blot analysis previously re-
vealed a number of cyc1-512 mRNAs, including 630-, 850-,
1,350-, and 1,450-nt and longer transcripts (88, 89), whereas
39-end mapping and sequencing further defined numerous
FIG. 1. Comparison of the growth of CBC11, cbc1-D, and cbc2-D strains. The
three isogenic strains were grown at 30°C on YPD glucose medium for 2 days,
YPG glycerol medium for 4 days, or YPR raffinose medium for 2 days. (A)
B-9037 (CBC11); (B) B-9038 (cbc1-D); (C) B-12463 (cbc2-D).
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transcripts between 630 and 700 nt (66). We have refined the
Northern blot analysis and detected the following eight tran-
scripts, as shown in Fig. 2 and schematically in Fig. 3: 630, 850,
1,450, 1,650, 1,850, 2,000, 2,400, and 3,500 nt. We have desig-
nated the 630- and 850-nt mRNAs the short cyc1-512 tran-
scripts and designated the 1,450- through 3,500-nt mRNAs the
long cyc1-512 transcripts.
Levels and degradation of mRNAs in cbc1-D and upf1-D
strains. The following series of isogenic strains was used for
examining the possibility that cbc1-D and upf1-D could act by
increasing the stability of cyc1-512 mRNAs and some other
specific mRNAs: B-9037 (cyc1-512), B-9038 (cyc1-512 cbc1-D),
B-9848 (cyc1-512 upf1-D), and B-11559 (cyc1-512 cbc1-D upf1-
D) (Table 1). The steady-state levels and half-lives of the fol-
lowing RNAs from these strains were determined by compar-
ing Northern blots after blocking transcription with the drug
thiolutin (24): the eight cyc1-512 mRNAs, ACT1 mRNA,
CYH2 mRNA, and CYH2 pre-mRNA. 18S rRNA was used as
an internal standard for Northern blots with total-RNA prep-
arations. In one experiment, where enriched poly(A) mRNA
was used to detect the low levels of the longer cyc1-512 tran-
scripts, ACT1 mRNA was used as an internal loading control,
adjusted for the known rate of decay of ACT1 mRNA in these
strains (Table 3). Examples of Northern blots (Fig. 2 and 4),
FIG. 2. Northern blot analyses of the eight cyc1-512 mRNAs listed in Table 3. Poly(A) RNA was extracted from four strains treated with 4 mg of thiolutin/ml for
0 to 30 min. (A and E) B-9037 (CBC11 UPF11); (B and F) B-9038 (cbc1-D UPF11); (C and G) B-9848 (CBC11 upf1-D); (D and H) B-11559 (cbc1-D upf1-D). (A to
D) cyc1-512 mRNAs; (E to H) ACT1 mRNA. The values presented in Table 3 were estimated from these blots by normalizing them to ACT1 mRNA values, whose
rates of degradation for these strains are known.
FIG. 3. Schematic representation of the cyc1-512 mRNAs, showing their lengths in nucleotides and the steady-state increases due to suppression by cbc1-D or
upf1-D.
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the decay curves (Fig. 5), and the steady-state levels and half-
lives (Table 3) are presented.
The half-lives clearly revealed that the degradation of cer-
tain mRNAs is greatly diminished by the upf1-D mutation. As
expected and as previously observed, the degradation of CYH2
pre-mRNA was greatly diminished in the upf1-D strain because
of the nonsense codon in the CYH2 intron (Fig. 4 and Table
3) (23), whereas that of CYH2 and ACT1 mRNAs was not
FIG. 4. Northern blot analysis of CYH2 mRNA and pre-mRNA (left) from strains B-9037 (CBC11 UPF11), B-9038 (cbc1-D UPF11), B-9848 (CBC11 upf1-D), and
B-11559 (cbc1-D upf1-D) treated with 4 mg of thiolutin/ml for 0 to 40 min as indicated above the blots. 18S rRNA is shown on the right-hand side.
FIG. 5. Decay in thiolutin-treated cells of cyc1-512 630-nt mRNA (A), CYH2 pre-mRNA (B), CYH2 mRNA (C), and ACT1 mRNA (D) from the following strains:
B-9037 (normal; cyc1-512) (F); B-9038 (cyc1-512 cbc1-D) (E); B-9848 (cyc1-512 upf1-D) (); and B-11559 (cyc1-512 cbc1-D upf1-D) (). The decay was determined
by Northern blot analysis of RNA extracted from cells treated with 4 mg of thiolutin/ml for 0 to 40 min. The results are presented as the percentage of remaining RNA
versus time of incubation in the presence of thiolutin.
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affected (Table 3). Most importantly, the degradation and
steady-state levels of the long cyc1-512 mRNAs were also di-
minished by two- to threefold, but not that of the short forms
(Fig. 2 and 3 and Table 3). As discussed below, we suggest that
the transcripts longer than 850 nt contain elements or struc-
tures that mimic the signals in mRNAs having premature ter-
minating codons.
The effect of the cbc1-D mutation was more complex, not
causing diminished degradation of the short (630- and 850-nt)
cyc1-512 mRNAs but causing a pronounced increase in their
steady-state levels (Fig. 3 and Table 3). The stabilities of the
short cyc1-512 mRNAs were the same in all four strains, but
their level are much higher in all cbc1-D strains (Fig. 2 and 3
and Table 3). This increase is unlikely to be the result of an
enhanced rate of transcription for the following two reasons.
(i) The relative levels of the short and long cyc1-512 mRNAs
were substantially different in the cyc1-512 and cyc1-512 cbc1-D
strains, which would not have been expected if this increase
were due to enhanced transcription. (ii) As discussed above,
cbc1-D did not have any enhancing effect on other CYC1 al-
leles. These observations suggest that the increased levels of
short (630- and 850-nt) cyc1-512 mRNAs in all cbc1-D strains
are due to a phenomenon designated promiscuous 39-end for-
mation (see Discussion).
In contrast, the longer cyc1-512 transcripts decayed more
rapidly in the CBC11 UPF11 strain than in the cbc1-D strains,
suggesting that degradation of these longer transcripts was
affected by the cbc1-D mutation, similar to the results with the
upf1-D mutation (see above) (Figs. 2A, B, and D). The stabil-
ities, as well as the steady-state levels, of the longer transcripts
increased by at least two- to threefold in all cbc1-D strains (Fig.
3 and Table 3). Furthermore, cbc1-D also slightly affected the
degradation of other RNAs tested, including ACT1 and CYH2
mRNA and CYH2 pre-mRNA (Table 3). Thus, Cbc1p may
play a role in the general degradation of all mRNAs.
Upf1-D, but not cbc1-D, suppresses nonsense mutations. Both
cbc1-D and upf1-D suppress cyc1-512 by increasing the levels of
one or another of the cyc1-512 mRNAs, but these suppressors
presumably act by different mechanisms. Although both cbc1-D
and upf1-D diminished the degradation of long cyc1-512
mRNAs, only upf1-D, but not cbc1-D, suppressed nonsense
mutations. This distinction was clearly revealed by testing the
leu2-1 (UAA), met8-1 (UAG), and his4-166 (UGA) markers
(Fig. 6), previously shown to be suppressed by upf1-D (42).
Furthermore, the steady-state level of the cyc1-72 mRNA, con-
taining a premature UAA mutation, was greatly enhanced in
the upf1-D strain but not in the cbc1-D strain (Fig. 7).
Suppression of rat7-1 by cbc1-D. Because Cbc1p is primarily
located in the nucleus (16), we considered the possibility that
the abnormally long cyc1-512 mRNAs are partially retained in
the nucleus and are subjected to a nuclear Cbc1p-dependent
degradation system. We have tested this hypothesis by inves-
tigating the decay of specific mRNAs at the restrictive temper-
ature of 37°C in rat7-1 strains, which do not grow or export
mRNAs under the restricted conditions (17). All of the rat7-1
strains used in this study were derived from the same strain
previously used by Gorsch et al. (17). ACT1 and CYH2 mRNAs,
as well as CYH2 pre-mRNA, were more rapidly degraded in
the rat7-1 strain than in the isogenic RAT71 strain when shifted
to 37°C (Fig. 8 and Table 4), although the values of the half-
lives of the CYH2 pre-mRNA in the rat7-1 and rat7-1 upf1-D
strains could not be accurately estimated because of rapid
degradation. Furthermore, degradation of all of the mRNAs
tested in rat7-1 strains was suppressed by cbc1-D but not upf1-D
(Fig. 8 and Table 4). Cbc1-D also suppressed the growth defect
inflicted by rat7-1 at 37°C (Fig. 9). As discussed below, we sug-
gest that Cbc1p could be required for degrading mRNAs ar-
rested in the nucleus.
DISCUSSION
We uncovered three phenomena by systematically investi-
gating two suppressors that partially restore the diminished
levels of iso-1-cytochrome c and mRNAs in the cyc1-512 mu-
tant that lacks the normal 39-end-forming signal. First, we
observed that degradation of the cyc1-512 mRNAs longer than
850 nt was suppressed in upf1-D mutants, which lack one of the
main components of the NMD pathway. Second, we found that
the long cyc1-512 mRNAs, and to some extent all mRNAs, are
degraded, presumably in the nucleus, in a Cbc1p-dependent
manner. This degradation is at least partially suppressed by
cbc1-D mutations and presumably is more pronounced with
mRNAs that are retained in the nucleus, either because of such
mutations as rat7-1 or because of structures of the mRNA,
such as abnormal extensions at the 39 end. Finally, transcrip-
tion termination and 39-end formation, which are diminished
because of incomplete or weak signals in the cyc1-512 allele,
were found to be enhanced by cbc1-D mutations, a phenome-
non we have designated promiscuous 39-end formation.
NMD of the long cyc1-512 mRNAs. The NMD pathway has
evolved as a surveillance mechanism to degrade transcripts
containing premature nonsense codons, thus preventing syn-
FIG. 6. cbc1-D does not suppress the nonsense mutations. Three strains,
B-11623 (UPF11 CBC11), B-9198 (UPF11 cbc1-D), and B-9199 (upf1-D
CBC11), were grown on YPD plates for 2 days, replicated onto omission media
lacking either leucine (2Leu), histidine (2His), or methionine (2Met) and
subsequently incubated for 3 days to test suppression of leu2-1 (UAA), his4-166
(UGA), and met8-1 (UAG).
FIG. 7. Northern blot analysis of B-11623 (cyc1-72), B-9198 (cyc1-72 cbc1-D),
and B-9199 (cyc1-72 upf1-D) showing the CYC1 steady-state mRNA levels com-
pared to the level of 18S ribosomal DNA (rDNA).
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thesis of incomplete and potentially deleterious proteins. In
particular, NMD protects cells from the potentially deleterious
effects of inefficient or inaccurate splicing, which are common
and which could result in the translation of mRNAs with in-
trons. Most introns contain nonsense codons and are therefore
subjected to NMD. Also, certain normal mRNAs are subjected
to NMD, presumably as a means to control steady-state levels
(82). Upf1p is a key component of the NMD pathway, which
exists in all eukaryotes that have been examined (9, 12, 32, 41,
46, 61, 85).
Muhlrad and Parker (48) and Hagen et al. (21) demon-
strated that NMD proceeds by decapping and subsequent deg-
radation by the action of the Xrn1p 59339 exoribonuclease.
Furthermore, studies of initiation of translation (30, 50) and
the presence of circular polyribosomes in electron micrographs
(31) have suggested that the 59 cap (or 59 untranslated region)
and the poly(A) tail are associated. This interaction between
the 59 cap and the poly(A) tail may prevent decapping (48). It
has been proposed that in-frame premature nonsense codons
near the 59 region cause release of the 80S ribosomes and
expose an element, designated the downstream element (55,
62, 63, 93) or the sensitive element (87), which is situated
downstream of the termination codon. One intriguing model
that has been proposed is that this element may mediate an
important interaction between a scanning ribosome or 40S
ribosomal subunit, a consequence of which would be rapid
decapping and degradation by Xrn1p, the major cytoplasmic
59339 exoribonuclease (56, 93). As discussed by Yun and Sher-
man (87), 40S ribosomal subunits and RNPs, as well as 80S
ribosomes, may serve to prevent interactions with these hypo-
thetical downstream elements.
The positions of the termination codons determine whether
the NMD will be triggered, and all of the yeast genes, URA3
(45), URA1 (54), PGK1 (55), HIS4 (21), and CYC1 (87), that
have been investigated showed very low abundance of mRNA
when the nonsense mutations were situated at or near the 59
regions and normal or nearly normal levels when the nonsense
mutations were in the 39 regions of the ORF. This position-
dependent triggering suggests that premature termination be-
fore the downstream elements is required for NMD. It has
been suggested that a surveillance complex, which is composed
of Upf1p and other proteins, scans 39 of the termination codon
for these elements. Peltz, Ruiz-Echevarrı´a, Zhang, and col-
leagues (55, 62, 63, 93) suggested that rapid decapping and
FIG. 8. Decay of ACT1 and CYH2 mRNAs and pre-mRNA at 37°C in
B-10603 (RAT71), B-10095 (rat7-1), B-10096 (rat7-1 cbc1-D), and B-10097
(rat7-1 upf1-D). The strains were grown at 23°C to the mid-log phase, shifted to
the restricted temperature of 37°C for 15 min, and subsequently treated with 4 mg
of thiolutin/ml to inhibit transcription, and the decay was followed for 0 to 50
min. Northern blots were probed for CYH2 mRNA (bottom band in each blot)
and pre-mRNA (top band in each blot) (A) and for ACT1 mRNA (B). The
numbers at the right denote the half-lives (t1/2) of the mRNAs in minutes.
FIG. 9. Growth of B-10603 (RAT71), B-10095 (rat7-1), B-10096 (rat7-1 cbc1-
D), and B-10097 (rat7-1 upf1-D) strains on YPD medium at 30 and 37°C for 3
days, showing the suppression of growth in rat7-1 strains by cbc1-D.
TABLE 4. Rates of decay of ACT1 and CYH2 mRNAs and
pre-mRNA in RAT71, rat7-1, rat7-1 cbc1-D, and rat7-1
upf1-D strains as described in Fig. 8
Strain Relevantgenotype
t1/2 (min)
ACT1 mRNA CYH2 mRNA CYH2 pre-mRNA
B-10603 RAT71 30 20 2.5
B-10095 rat7-1 12 3 ,1
B-10096 rat7-1 cbc1-D 28 12 5
B-10097 rat7-1 upf1-D 14 4.5 ,1
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59339 decay of the mRNA occurs when the surveillance com-
plex interacts with the downstream element. The sequence of
the downstream element is degenerate and is present numer-
ous times in virtually all mRNAs (93).
The NMD of cyc1-512 mRNAs can be simply explained by
the presence of downstream elements, or structures in the
extended 39 region, specifically between 850 and 1,450 nt, as
schematically presented in Fig. 3. In fact, the lack of a down-
stream element in such a large segment would be highly un-
likely, in view of the fact that all or most mRNAs with prema-
ture nonsense mutations are subjected to the NMD pathway.
Thus, it is reasonable to suggest that the same mechanism is
used for degrading long cyc1-512 mRNAs and wild-type
mRNAs that are targets of NMD. Our discovery of the involve-
ment of the UPF1 gene in the degradation of long cyc1-512
mRNAs defines a novel class of substrates of the NMD path-
way, which confirmed similar observations by Muhlrad and
Parker (49). The cyc1-512 type of mRNA with extended 39
sequences differs from the mRNAs subjected to NMD by leaky
scanning within ORFs (82).
The reduction in mRNA level caused by a mutation or
deletion of the poly(A) signals has also been observed in the
r293 mutation of the unc-54 gene in Caenorhabditis elegans,
which involves deletion of the poly(A) signal in the myosin
heavy chain B mRNA (58), and in human thalassemias result-
ing from mutations in the conserved AAUAAA polyadenyla-
tion signal (26, 52, 64). In C. elegans, several smg mutations
were shown to suppress the unc-54 (r293) mutation, resulting
in near-normal amounts of the unc-54 (r293) mRNA (8, 58).
Two other deletion mutations that removed the polyadenyla-
tion site, unc-17 (p1156) and unc-17 (md1447), were also sup-
pressed by the smg suppressors (J. M. Rand, personal commu-
nication). One of the smg genes, smg-2, is homologous to the
yeast UPF1 gene (53), suggesting conservation of a mechanism
which restricts the levels of abnormal mRNAs.
Cbc1p-dependent mRNA degradation. The identity of SUT1
and CBC1 established a role of the nuclear cap binding pro-
tein, Cbc1p, in mRNA degradation. CBC is composed of two
proteins designated CBP80 and CBP20 in higher eukaryotes
(28, 29, 34, 35, 51) and Cbc1p and Cbc2p, respectively, in yeast.
Mutant forms of CBC1 and CBC2 have been uncovered in
other genetic screens, and CBC1 has been previously desig-
nated not only SUT1 but also GCR3 (77, 78) and STO1 (11),
whereas CBC2 has also been designated MUD13 (11). CBC
binds to nuclear RNAs containing the capped 7-methyl-gua-
nosine structure and, at least in mammalian cells, is involved in
pre-RNA splicing, poly(A) site cleavage, and snRNA export
(15, 28, 29, 34, 35, 51). Although CBC translocates through
nuclear pore complexes attached to the 59 ends of mRNPs in
higher eukaryotes (81), it does not appear to play a direct role
in their export. Similar to higher-eukaryotic CBC, yeast CBC is
primarily located in the nucleus and functions in pre-RNA
splicing (11, 43).
The requirement for CBC in pre-RNA splicing was revealed
from the findings that immunodepletion of CBP80 greatly di-
minishes the activity in vitro of splicing extracts from higher-
eukaryotic cells (29) and yeast (43). In addition, cbc2-D strains
have diminished pre-mRNA splicing efficiency in vitro and the
cbc2-D mutation is synthetically lethal with a U1 snRNA mu-
tation (11). Similarly, evidence for the role of CBC in 39-end
formation was obtained by Flaherty et al. (15) using HeLa ex-
tracts with CBP80 immunodepleted. Cleavage of capped pre-
RNA was inhibited to approximately 80%, whereas polyadeny-
lation of a precleaved substrate was not significantly affected.
Although the primary sequence and the function in splicing
of CBC are conserved from yeast to humans, CBC is not
essential for growth in yeast. Growth of cbc1-D strains is se-
verely retarded on glucose medium but only mildly diminished
on glycerol and raffinose media. The dispensability of CBC in
vivo can be explained by only a partial diminution of splicing
and near-normal export of the bulk of polyadenylated RNAs in
cbc1-D strains. Also, the role of CBC in the export of U
snRNAs has not been demonstrated in yeast.
We have presented evidence that Cbc1p is involved in the
rapid decay of long cyc1-512 mRNAs without affecting the
decay rates of shorter 630- and 850-nt transcripts. Interestingly,
the degradation of short cyc1-512 mRNAs followed at least
two-component decay kinetics in a CBC11 UPF11 strain, in-
dicative of heterogeneous mRNA molecules having different
half-lives (Fig. 5A). We suggest that the long cyc1-512 mRNAs
are undergoing rapid degradation in the CBC11 UPF11 strains
by Cbc1p- and Upf1p-dependent degradation systems, and
these partially degraded products of the long forms are situ-
ated at the same positions as the 630- and 850-nt bands, thus
contributing to the heterogeneous mRNA molecules having
different half-lives.
The major question resulting from this work is the nature of
the mRNA degradation that is dependent on Cbc1p, or pre-
sumably on CBC, since both cbc1-D and cbc2-D equally sup-
pressed cyc1-512. The decay of longer labile cyc1-512 mRNAs
was diminished in both the cbc1-D and upf1-D strains, whereas
the degradation of the transcripts containing premature non-
sense codons, such as cyc1-72 mRNA and CYH2 pre-mRNA,
was diminished in only the upf1-D strain. On the other hand,
only the cbc1-D mutation stabilized all mRNAs arrested in the
nucleus in the rat7-1 strain and slightly stabilized all mRNAs in
RAT71 normal strains.
The similarity in the degree of suppression of decay of the
long cyc1-512 mRNAs by single upf1-D and cbc1-D strains and
by the double upf1-D cbc1-D strains (Table 2) could suggest
that Cbc1p and Upf1p are part of the same degradation path-
way. In this regard it should be noted that the mRNA decay
function can be separated from the activity modulating trans-
lation termination at nonsense codons (83, 84). For example, a
subset of upf1 mutations which altered the Upf1p helicase
region inactivated the decay activity but did not cause non-
sense suppression (83), while another, different subset of upf1
mutations with alterations in an amino-terminal region of
Upf1p suppressed certain nonsense mutations without pre-
venting the NMD. Thus, it is reasonable to assume that dele-
tion of certain components of the NMD pathway would dimin-
ish the decay properties without acting as suppressors. Hence,
one could suggest that cbc1-2 or cbc1-D represents such a
mutation that affects decay but not suppression of nonsense
mutation and Cbc1p is part of the NMD pathway. One could
further suggest that NMD takes place in both the nucleus and
the cytoplasm but Cbc1p functions in this pathway solely in the
nucleus. The finding that Upf3p is a nucleus- and cytosol-
shuttling protein in yeast (74) and that NMD of newly synthe-
sized mRNA copurifies with nuclei of mammalian cells (90–92)
is consistent with this view.
However, the following lines of evidence indicate that NMD
occurs in yeast with transcripts translated on cytoplasmic poly-
somes: Upf1p, Upf2p, and Upf3p are associated with poly-
somes (3, 4, 55, 56); NMD can be suppressed with tRNA
nonsense suppressors (5, 18, 45); a cycle of initiation and ter-
mination is required for NMD, and translation reinitiation can
prevent activation of NMD (61, 63, 87, 90); and nonsense
codon-containing RNAs lose and regain their decay properties
by the addition and removal, respectively, of the translational
inhibitor cycloheximide (90). We favor the view that Cbc1p-
dependent degradation is independent of NMD, because there
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is no evidence that CBC is associated with mRNAs during
translation on polysomes and because CBC is primarily situ-
ated in the nucleus with only a brief exposure in the cytoplasm
as part of the nuclear transport cycle. Furthermore, the decay
of CYH2 pre-mRNA in rat7-1 strains was not specifically di-
minished in cbc1-D strains, which is one of the natural sub-
strates for NMD (Fig. 8A and Table 4), indicating that Cbc1p
is not involved in the degradation of substrates containing
premature nonsense codons.
Thus, we suggest that Cbc1p-dependent degradation takes
place in the nucleus and may be related to the stimulatory
effect of CBC on pre-mRNA processing, including splicing
and cleavage during 39-end formation. We also argue that all
mRNAs located in the nucleus are degraded by the Cbc1p-
dependent pathway and that the net destruction of a particular
mRNA is dependent on the length of time spent in the nucleus.
Even though there is no direct evidence, we hypothesize that
the long cyc1-512 mRNAs are preferentially retained in the
nucleus and we further suggest that this retention in the nu-
cleus is responsible for their high susceptibility to the Cbc1p-
dependent degradation system.
The hypothesis that Cbc1p is part of a degradation system
acting on mRNAs retained in the nucleus is also supported by
the suppression of rat7-1 by cbc1-D. Rat7p is an essential nu-
cleoporin 1,450 amino acids long that apparently plays a direct
role in the nucleocytoplasmic export of mRNA (13, 17). The
rat7-1 mutation is a single-base pair change introducing a pre-
mature stop codon approximately 100 amino acids upstream
from the C terminus (13). After rat7-1 cells are shifted to 37°C,
the restrictive temperature, there is a cessation of growth and
of mRNA export, resulting in a diminished level of cytoplasmic
mRNAs. We have observed that the stabilities of CYH2 mRNA
and pre-mRNA, ACT1 mRNA, and presumably other mRNAs
were greatly diminished in the rat7-1 mutants grown at 37°C
compared to those in a corresponding isogenic RAT71 strain
(Fig. 8), a condition that allows growth of the RAT71 strain.
Most importantly, cbc1-D rescues both the rat7-1 phenotypes,
lack of growth (Fig. 9) and instability of ACT1 and CYH2
mRNAs and CYH2 pre-mRNA at 37°C (Fig. 8).
While the cbc1-D suppression of rat7-1 at 37°C can be inter-
preted in several ways, including the suppression of the dimin-
ished export, we favor the view that nuclear retention of
mRNAs in rat7-1 strains results in increased degradation by
the action of the Cbc1p-dependent degradation system. This
nuclear degradation leads to diminished levels of mRNAs that
are available for the already abnormally reduced export to the
cytoplasm. In other words, the suppression of rat7-1 by cbc1-D
could be envisioned as enhancing the levels of nuclear mRNAs
and thus allowing the defective transport system to produce a
higher level of cytoplasmic mRNAs required for viability. Re-
cently, Uemura et al. (78) reported that a cbc1 mutation sup-
pressed the temperature-sensitive growth of hpr1 mutants,
which are conditionally defective in the nuclear export of
poly(A) RNA (68). We believe that cbc1 suppression of both
hpr1 and rat7-1 may be operating by the same mechanism. It
remains to be seen if cbc1 suppression of hpr1 and rat7-1 is due
to diminished degradation of mRNAs retained in the nucleus
or to reversal of the mRNA transport defects.
There are a few known ribonucleases that possibly could be
components of the Cbc1p-dependent nuclear degradation sys-
tem. Two possible candidates are Rrp6p, which is a nuclear
39359 riboexonuclease (6, 7), and Rat1p, which is a nuclear
59339 riboexonuclease (2, 33, 37, 57, 75). Burkard and Butler
(7) suggested that Rrp6p plays a role in a nuclear RNA decay
pathway that destroys slowly processed mRNAs. Furthermore,
two-hybrid analyses and coimmunoprecipitation experiments
demonstrated that Rrp6p interacts with Npl3p and Cbc1p (7;
K. T. Burkard and J. S. Butler, personal communication). Fur-
ther studies, which are in progress, would reveal the role of
Cbc1p and other components in the nuclear degradation sys-
tem.
Promiscuous 3*-end formation. The finding of higher levels
of 630- and 850-nt cyc1-512 mRNAs in cbc1-D mutants, with-
out a corresponding increase in the half-lives (Table 3), sug-
gested that the enhanced levels were due to more efficient
39-end formation at these normally weak sites. Extensive work
(reviewed in references 19 and 20) has established that 39-end-
forming signals in yeast consist of three elements: (i) the effi-
ciency element, which enhances the efficiency of downstream
positioning elements; (ii) the positioning element, which posi-
tions the poly(A) site; and (iii) the actual poly(A) site. These
three elements are not only necessary but also sufficient for
mRNA 39-end formation in yeast. However, when the effi-
ciency element is absent or lacks the optimum sequence, low
levels of mRNA having the corresponding poly(A) site are still
observed. It is believed that a portion of the mRNA molecules
terminate at this site, whereas the bulk of the mRNA bypasses
the site but can terminate downstream if a stronger signal is
present. We used the term “preferred sites” to denote these
discrete sites of mRNA 39 ends in the cyc1-512 mutant that are
used by the revertants and the normal CYC11 strain (65).
Apparently, the cbc1-D mutation enhances 39-end formation at
the 630- and 850-nt preferred sites, thereby acting as a sup-
pressor of cyc1-512 without affecting the half-lives of these
short mRNAs.
Numerous trans-acting factors have been shown to play roles
in 39-end formation in yeast, including approximately 20 gene
products that have direct roles in the processing of pre-
mRNAs in vitro (36). In particular, Hrp1p appears to stabilize
the assembly of the cleavage complex at an authentic poly(A)
site (47). Furthermore, Hrp1p directly interacts with the UAU
AUA efficiency element (10, 38, 80). Our results with en-
hanced 39-end formation at the 630- and 850-nt preferred sites
in the cyc1-512 mRNAs lacking the efficiency elements suggest
that CBC plays a role in the fidelity of this interaction and that
promiscuous 39-end formation can occur with mRNAs lacking
the nuclear cap binding proteins.
Thus, studies with the upf1-D, cbc1-D, and cbc2-D mutants
led to the following major conclusions: transcripts with ex-
tended 39 untranslated regions could be recognized as sub-
strates for NMD, even though the mRNAs lack a premature
termination codon in the ORF; Cbc1p and Cbc2p are compo-
nents of a novel mRNA decay pathway, which presumably acts
in the nucleus; and Cbc1p and Cbc2p are required for high-
fidelity 39-end formation at certain sites. It is reasonable to
suggest that either the upf1-D or cbc1-D mutations preferen-
tially affect the levels of certain normal mRNAs. For example,
cbc1-D could cause the overproduction of certain normal genes
that are usually subjected to degradation by a Cbc1p-depen-
dent pathway. Abnormal mRNA levels could account for di-
versed and unrelated phenotypes, such as inhibition of growth
by glucose-repressing conditions (see above) (77, 78) and in-
crease in the negative superhelicity of plasmids (78).
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